Bellus Health Total Assets 2006-2020 | BLU

Bellus Health total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Bellus Health Annual Total Assets
(Millions of US $)
2019 $94
2018 $41
2017 $22
2016 $7
2015 $12
2014 $15
2013 $23
2012 $27
2011 $12
2010 $20
2009 $28
2008 $32
2007 $78
2006 $71
2005 $83
Bellus Health Quarterly Total Assets
(Millions of US $)
2020-06-30 $127
2020-03-31 $132
2019-12-31 $96
2019-09-30 $104
2019-06-30 $35
2019-03-31 $38
2018-12-31 $41
2018-09-30 $17
2018-06-30 $19
2018-03-31 $20
2017-12-31 $22
2017-09-30 $9
2017-06-30 $9
2017-03-31 $9
2016-12-31 $7
2016-09-30 $9
2016-06-30 $10
2016-03-31 $10
2015-12-31 $12
2015-09-30 $11
2015-06-30 $12
2015-03-31 $13
2014-12-31 $15
2014-09-30 $19
2014-06-30 $20
2014-03-31 $20
2013-12-31 $23
2013-09-30 $23
2013-06-30 $22
2013-03-31 $26
2012-12-31 $27
2012-09-30 $28
2012-06-30 $28
2012-03-31 $12
2011-12-31 $12
2011-09-30 $13
2011-06-30 $14
2011-03-31 $17
2010-12-31 $20
2010-09-30 $19
2010-06-30 $25
2010-03-31 $24
2009-12-31 $28
2009-09-30 $32
2009-06-30 $27
2009-03-31 $18
2008-12-31 $32
2008-09-30 $44
2008-06-30 $49
2008-03-31 $63
2007-12-31 $78
2007-09-30 $94
2007-06-30 $109
2007-03-31 $53
2006-12-31 $71
2006-09-30 $0
2005-12-31 $83
2005-09-30 $89
2005-06-30 $93
2005-03-31 $106
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.146B $0.000B
BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.829B 10.46
Amgen (AMGN) United States $134.106B 14.57
CSL (CSLLY) Australia $95.578B 0.00
Gilead Sciences (GILD) United States $75.487B 10.87
Regeneron Pharmaceuticals (REGN) United States $60.899B 23.29
Vertex Pharmaceuticals (VRTX) United States $55.058B 30.72
Illumina (ILMN) United States $46.406B 53.96
Biogen (BIIB) United States $42.572B 7.35
Seattle Genetics (SGEN) United States $34.401B 0.00
BeiGene (BGNE) Cayman Islands $27.423B 0.00
Moderna (MRNA) United States $26.978B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.904B 10.79
Genmab (GMAB) Denmark $23.167B 14.62
Genmab (GNMSF) Denmark $21.854B 5.03
Immunomedics (IMMU) United States $20.299B 0.00
BioNTech SE (BNTX) Germany $19.848B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $19.377B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.828B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Horizon Therapeutics Public (HZNP) Ireland $15.334B 35.88
Exact Sciences (EXAS) United States $14.958B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.055B 101.97
ARGENX SE-ADR (ARGX) Netherlands $12.072B 0.00
MyoKardia (MYOK) United States $11.788B 0.00
QIAGEN (QGEN) Netherlands $11.520B 29.24
Sarepta Therapeutics (SRPT) United States $10.776B 0.00
Bio-Techne Corp (TECH) United States $10.094B 69.26
Guardant Health (GH) United States $9.938B 0.00
Repligen (RGEN) United States $9.018B 143.13
Ascendis Pharma (ASND) Denmark $8.245B 0.00
Mirati Therapeutics (MRTX) United States $8.237B 0.00
Galapagos (GLPG) Belgium $8.043B 29.10
Exelixis (EXEL) United States $6.733B 24.48
CRISPR Therapeutics AG (CRSP) Switzerland $6.471B 200.48
ACADIA Pharmaceuticals (ACAD) United States $6.471B 0.00
Acceleron Pharma (XLRN) United States $6.393B 0.00
Adaptive Biotechnologies (ADPT) United States $6.375B 0.00
Novavax (NVAX) United States $5.586B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.571B 15.22
Blueprint Medicines (BPMC) United States $5.536B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.400B 0.00
Emergent Biosolutions (EBS) United States $4.924B 19.50
NeoGenomics (NEO) United States $4.652B 1404.33
Amicus Therapeutics (FOLD) United States $4.565B 0.00
China Biologic Products (CBPO) China $4.465B 26.50
Vir Biotechnology (VIR) United States $4.392B 0.00
Arena Pharmaceuticals (ARNA) United States $4.382B 0.00
Denali Therapeutics (DNLI) United States $4.203B 0.00
Halozyme Therapeutics (HALO) United States $4.119B 0.00
Fate Therapeutics (FATE) United States $3.861B 0.00
Twist Bioscience (TWST) United States $3.851B 0.00
Reata Pharmaceuticals (RETA) United States $3.841B 0.00
Insmed (INSM) United States $3.712B 0.00
Bluebird Bio (BLUE) United States $3.599B 0.00
MorphoSys AG (MOR) Germany $3.432B 44.98
Legend Biotech (LEGN) United States $3.421B 0.00
Global Blood Therapeutics (GBT) United States $3.412B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.394B 0.00
Eidos Therapeutics (EIDX) United States $2.811B 0.00
Alkermes (ALKS) Ireland $2.586B 54.20
I-Mab (IMAB) China $2.326B 0.00
PHARMA MAR SA (PHMMF) Spain $2.294B 0.00
Seres Therapeutics (MCRB) United States $2.150B 0.00
Sorrento Therapeutics (SRNE) United States $2.055B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.029B 0.00
Editas Medicine (EDIT) United States $1.885B 0.00
Zymeworks (ZYME) Canada $1.855B 0.00
Amarin (AMRN) Ireland $1.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Inovio Pharmaceuticals (INO) United States $1.759B 0.00
UniQure (QURE) Netherlands $1.756B 0.00
Intra-Cellular Therapies (ITCI) United States $1.681B 0.00
Viela Bio (VIE) United States $1.657B 0.00
Revance Therapeutics (RVNC) United States $1.561B 0.00
Beam Therapeutics (BEAM) United States $1.536B 0.00
Zealand Pharma (ZEAL) Denmark $1.531B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Sangamo Therapeutics (SGMO) United States $1.462B 0.00
Northwest Biotherapeutics (NWBO) United States $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.418B 0.00
Intellia Therapeutics (NTLA) United States $1.380B 0.00
Epizyme (EPZM) United States $1.360B 0.00
Mesoblast (MESO) Australia $1.319B 0.00
Ligand Pharmaceuticals (LGND) United States $1.295B 43.78
Arcus Biosciences (RCUS) United States $1.266B 0.00
Mersana Therapeutics (MRSN) United States $1.224B 0.00
Coherus BioSciences (CHRS) United States $1.184B 6.90
Alcobra (ARCT) United States $1.153B 0.00
NGM Biopharmaceuticals (NGM) United States $1.141B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.114B 0.00
Cytokineticsorporated (CYTK) United States $1.107B 0.00
Heska (HSKA) United States $1.088B 0.00
Myriad Genetics (MYGN) United States $1.054B 0.00
Retrophin (RTRX) United States $1.049B 0.00
Genetron Holdings (GTH) China $1.021B 0.00
REGENXBIO (RGNX) United States $1.012B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.972B 0.00
Castle Biosciences (CSTL) United States $0.959B 0.00
Athenex (ATNX) United States $0.955B 0.00
Compugen (CGEN) Israel $0.954B 0.00
Adverum Biotechnologies (ADVM) United States $0.942B 0.00
Vericel (VCEL) United States $0.887B 0.00
Codexis (CDXS) United States $0.824B 0.00
NantKwest (NK) United States $0.822B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.811B 0.00
Pliant Therapeutics (PLRX) United States $0.810B 0.00
Morphic Holding (MORF) United States $0.803B 0.00
Arvinas (ARVN) United States $0.792B 0.00
Intrexon (PGEN) United States $0.772B 0.00
Alector (ALEC) United States $0.746B 0.00
Agenus (AGEN) United States $0.741B 0.00
Cellectis S.A (CLLS) France $0.726B 0.00
Protagonist Therapeutics (PTGX) United States $0.717B 0.00
MiMedx (MDXG) United States $0.712B 0.00
Frequency Therapeutics (FREQ) United States $0.709B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
AnaptysBio (ANAB) United States $0.690B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Celldex Therapeutics (CLDX) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Syndax Pharmaceuticals (SNDX) United States $0.603B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.589B 0.00
Kadmon Holdings (KDMN) United States $0.585B 0.00
VBI Vaccines (VBIV) United States $0.585B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Geron (GERN) United States $0.568B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.548B 4.79
IVERIC Bio (ISEE) United States $0.536B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.531B 0.00
Albireo Pharma (ALBO) United States $0.517B 0.00
Anika Therapeutics (ANIK) United States $0.509B 22.25
Cel-Sci (CVM) United States $0.494B 0.00
Clovis Oncology (CLVS) United States $0.484B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.484B 0.00
MeiraGTx Holdings (MGTX) United States $0.477B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.470B 0.00
MannKind (MNKD) United States $0.463B 0.00
Dynavax Technologies (DVAX) United States $0.457B 0.00
Avid Bioservices (CDMO) United States $0.452B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.448B 0.00
Amryt Pharma (AMYT) United Kingdom $0.433B 0.00
Sutro Biopharma (STRO) United States $0.432B 0.00
Starpharma Holdings (SPHRY) Australia $0.427B 0.00
Kala Pharmaceuticals (KALA) United States $0.426B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.411B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Cue Biopharma (CUE) United States $0.390B 0.00
Forte Biosciences (FBRX) United States $0.378B 0.00
Merus (MRUS) Netherlands $0.375B 0.00
Puma Biotechnology (PBYI) United States $0.371B 0.00
Kamada (KMDA) Israel $0.370B 17.66
Xenon Pharmaceuticals (XENE) Canada $0.367B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.347B 0.00
Trevena (TRVN) United States $0.341B 0.00
IBio (IBIO) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.340B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 7.93
Bicycle Therapeutics (BCYC) United Kingdom $0.335B 0.00
Spero Therapeutics (SPRO) United States $0.334B 0.00
BioDelivery Sciences (BDSI) United States $0.330B 23.36
Syros Pharmaceuticals (SYRS) United States $0.330B 0.00
AC Immune SA (ACIU) Switzerland $0.321B 0.00
Athersys (ATHX) United States $0.318B 0.00
NextCure (NXTC) United States $0.313B 0.00
Innate Pharma S.A (IPHA) France $0.309B 0.00
ChromaDex (CDXC) United States $0.305B 0.00
CytomX Therapeutics (CTMX) United States $0.303B 0.00
WAVE Life Sciences (WVE) Singapore $0.299B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.297B 0.00
Cardiff Oncology (CRDF) United States $0.285B 0.00
Selecta Biosciences (SELB) United States $0.279B 0.00
PDL BioPharma (PDLI) United States $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Affimed (AFMD) Germany $0.249B 0.00
TELA Bio (TELA) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.226B 0.00
Arbutus Biopharma (ABUS) United States $0.226B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.223B 0.00
XOMA (XOMA) United States $0.216B 0.00
HOOKIPA Pharma (HOOK) United States $0.212B 0.00
Verastem (VSTM) United States $0.207B 0.00
Dyadic (DYAI) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.201B 0.00
ADMA Biologics Inc (ADMA) United States $0.187B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Aptinyx (APTX) United States $0.183B 0.00
Eton Pharmaceuticals (ETON) United States $0.183B 0.00
CorMedix Inc (CRMD) United States $0.175B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
GENFIT S.A (GNFT) France $0.170B 0.00
Biofrontera AG (BFRA) Germany $0.167B 0.00
DBV Technologies S.A (DBVT) France $0.167B 0.00
Theratechnologies (THTX) Canada $0.163B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.152B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.149B 6.95
Exicure (XCUR) United States $0.147B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
Prometic Life Sciences (LMNL) Canada $0.142B 0.00
SESEN BIO, INC (SESN) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Strongbridge Biopharma (SBBP) United States $0.115B 0.00
Celyad SA (CYAD) Belgium $0.114B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Unum Therapeutics (COGT) United States $0.114B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.61
Gritstone Oncology (GRTS) United States $0.108B 0.00
Abeona Therapeutics (ABEO) United States $0.105B 0.00
AIT Therapeutics (XAIR) United States $0.103B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.103B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.101B 0.00
Antibe Therapeutics (ATBPF) Canada $0.101B 0.00
Oncobiologics (OTLK) United States $0.098B 0.00
Palatin Technologies (PTN) United States $0.096B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
Cyclerion Therapeutics (CYCN) United States $0.088B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Evogene (EVGN) Israel $0.085B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) United States $0.076B 72.50
Idera Pharmaceuticals (IDRA) United States $0.074B 0.00
Bionano Genomics (BNGO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Organovo Holdings (ONVO) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Appili Therapeutics (APLIF) Canada $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
AmpliPhi Biosciences (ARMP) United States $0.065B 0.00
Curis (CRIS) United States $0.063B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Edesa Biotech (EDSA) Canada $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
TRACON Pharmaceuticals (TCON) United States $0.051B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Novogen (KZIA) Australia $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.038B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.037B 0.00
Apricus Biosciences (SEEL) United States $0.035B 0.00
OvaScience (MLND) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioPharmX (TMBR) United States $0.018B 0.00
Cesca Therapeutics (THMO) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00